Max Robotics — Global Service Robot Directory + US Certification

About

Ryo Amakawa is a urological surgeon whose research focuses on advancing perioperative care and surgical techniques in urologic oncology, particularly for bladder, prostate, and kidney cancers. His most impactful work centers on implementing Enhanced Recovery After Surgery (ERAS) protocols in robot-assisted radical cystectomy (RARC) and radical prostatectomy, demonstrating that these multidisciplinary perioperative pathways can reduce complications and shorten hospital stays—a significant shift from traditional urological practice. Amakawa’s 2023 paper on ERAS in RARC has garnered 9 citations, reflecting growing interest in optimizing recovery for major cancer surgery. He has also contributed to nephron-sparing surgery, assessing outcomes of off-clamp open partial nephrectomy without renorrhaphy for larger renal tumors (≥T1b), achieving 7 citations for this work. By systematically evaluating surgical innovations and recovery protocols, Amakawa bridges the gap between minimally invasive techniques and evidence-based perioperative care. His research not only enhances patient outcomes but also provides a framework for integrating ERAS into urological surgery, making him a notable contributor to the field’s evolution toward faster, safer recovery pathways.